NIAID conducts and supports clinical trials evaluating therapies and vaccine candidates against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), the virus that causes COVID-19.NIAID’s research program to develop safe and effective antivirals to combat SARS-CoV-2 will also build sustainable platforms for targeted drug discovery and development of antivirals against viruses with pandemic potential.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.